[1] Bedell SL, Goldstein LS, Goldstein AR, et al.  Cervical cancer screening: past, present, and future[J]. Sex Med Rev, 2020, 8(1): 28-37.   doi: 10.1016/j.sxmr.2019.09.005
[2] Wright JD, Chen L, Tergas AI, et al.  Population-level trends in relative survival for cervical cancer[J]. Am J Obstet Gynecol, 2015, 213(5): 670. e1-670. e7.   doi: 10.1016/j.ajog.2015.07.012
[3] Zhang Y, Li P, Hu J, et al.  Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance[J]. Biochem Biophys Res Commun, 2019, 508(1): 210-216.   doi: 10.1016/j.bbrc.2018.11.110
[4]

Liu XQ, Tian H, Li H, et al. Derivate isocorydine (d-ICD) suppresses migration and invasion of hepatocellular carcinoma cell by downregulating ITGA1 expression[J/OL]. Int J Mol Sci, 2017, 18(3): 514[2020-04-19]. https://www.mdpi.com/1422-0067/18/3/514. DOI: 10.3390/ijms18030514.
[5]

梁雪霏. 异紫堇碱在宫颈癌SiHa细胞中通过逆上皮间充质转化途径实现抗癌作用[D]. 兰州: 兰州大学, 2016.

Liang XF. Isocorydine controls cell differentiation through mesenchvmal-to-epithelial transition in SiHa cervical cancer cell[D]. Lanzhou: Lanzhou University, 2016.
[6] Podralska M, Ciesielska S, Kluiver J, et al.  Non-coding RNAs in cancer radiosensitivity: microRNAs and lncRNAs as regulators of radiation-induced signaling pathways[J]. Cancers (Basel), 2020, 12(6): 1662-.   doi: 10.3390/cancers12061662
[7] Wang YF, Yang HY, Shi XQ, et al.  Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer[J]. Cancer Biol Ther, 2018, 19(12): 1162-1173.   doi: 10.1080/15384047.2018.1491497
[8] Chiang KC, Lai CY, Chiou HL, et al.  Timosaponin AⅢ inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT/miR-129-5p axis[J]. J Cell Physiol, 2019, 234(8): 13332-13341.   doi: 10.1002/jcp.28010
[9] Bray F, Ferlay J, Soerjomataram I, et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.   doi: 10.3322/caac.21492
[10] Wu NYY, Zhang XY, Chu TY, et al.  High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis[J]. Ann Transl Med, 2019, 7(14): 328-.   doi: 10.21037/atm.2019.06.15
[11] Tornero-López AM, Guirado D.  Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer[J]. Rep Pract Oncol Radiother, 2018, 23(6): 562-573.   doi: 10.1016/j.rpor.2018.05.007
[12]

Lin M, Ye MM, Zhou JH, et al. Recent advances on the molecular mechanism of cervical carcinogenesis based on systems biology technologies[J/OL]. Comput Struct Biotechnol J, 2019, 17: 241−250[2020-04-19]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389684. DOI: 10.1016/j.csbj.2019.02.001.
[13] Fan L, Huang CX, Li J, et al.  Long non-coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer[J]. Int J Mol Med, 2018, 42(4): 2247-2259.   doi: 10.3892/ijmm.2018.3778
[14]

Pan JX, Chen G, Li JJ, et al. Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma[J/OL]. Am J Cancer Res, 2018, 8(1): 154−164[2020-04-19]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794729.
[15] 黄涛, 关德凤, 杨永秀.  异紫堇碱对人子宫内膜腺癌细胞系-1B细胞增殖、凋亡及迁移的影响[J]. 兰州大学学报: 医学版, 2019, 45(2): 26-32.   doi: 10.13885/j.issn.1000-2812.2019.02.004
Huang T, Guan DF, Yang YX.  Effects of isocorydine on proliferation, apoptosis and migration of human endometrial adenocarcinoma cell-1B[J]. J Lanzhou Univ (Med Sci), 2019, 45(2): 26-32.   doi: 10.13885/j.issn.1000-2812.2019.02.004
[16]

黄涛. 异紫堇碱通过PI3K/AKT/NF-κB通路抑制子宫内膜癌细胞系HEC-1B细胞增殖、凋亡、迁移的分子机制[D]. 兰州: 兰州大学, 2019.

Huang T. Molecular mechanism of isocorydine inhibiting proliferation, apoptosis and migration of endometrial cancer cell line HEC-1B by PI3K/AKT/NF-κB pathway[D]. Lanzhou: Lanzhou University, 2019.
[17] Wei YQ, Jiao XL, Zhang SY, et al.  MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5[J]. Eur Rev Med Pharmacol Sci, 2019, 23(17): 7314-7326.   doi: 10.26355/eurrev_201909_18837
[18] Wu YQ, Huang J, Xu HZ, et al.  Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52[J]. Biomed Pharmacother, 2018, 105: 1325-1334.   doi: 10.1016/j.biopha.2018.06.033
[19]

Ding FN, Gao BH, Wu X, et al. miR-122-5p modulates the radiosensitivity of cervical cancer cells by regulating cell division cycle 25A (CDC25A)[J/OL]. FEBS Open Bio, 2019, 9(11): 1869−1879[2020-04-19]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823283. DOI: 10.1002/2211-5463.12730.
[20] Liu Y, Liang GD, Wang H, et al.  MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6[J]. Pathol Res Pract, 2019, 215(12): 152641-.   doi: 10.1016/j.prp.2019.152641
[21] Wang Q, Yu JH.  MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1[J]. Biochem Cell Biol, 2018, 96(1): 19-25.   doi: 10.1139/bcb-2016-0254
[22] Shi Y, Gong WH, Lu L, et al.  Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells[J]. Braz J Med Biol Res, 2019, 52(11): e8657-.   doi: 10.1590/1414-431X20198657
[23] Che YL, Li YZ, Zheng FF, et al.  TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling[J]. Cancer Lett, 2019, 452: 1-13.   doi: 10.1016/j.canlet.2019.03.017